New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
07:37 EDTLPTNLpath's anti-LPA antibody shows positive results in brain injury models
Lpath's Lpathomab, a therapeutic antibody, has shown to reverse much of the damage caused by trauma to the nervous system in traumatic brain injury, according to a recent publication. Lpathomab can be used to reduce the size of a TBI and to improve functional behavioral outcomes in experimental animal models. The antibody was tested in mice that had TBIs.
News For LPTN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
10:42 EDTLPTNSabby Management reports 9.99% passive stake in Lpath
September 19, 2014
08:39 EDTLPTNLpath raises $12.5M in a registered direct offering
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use